These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 24302582)

  • 1. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?
    Qiao JJ; Chan TH; Qin YR; Chen L
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):865-8. PubMed ID: 24928581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
    Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
    Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.
    Zhang J; Chen Z; Tang Z; Huang J; Hu X; He J
    Tumour Biol; 2017 Jul; 39(7):1010428317708546. PubMed ID: 28714361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
    Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
    Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
    Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA editing of
    Fu L; Qin YR; Ming XY; Zuo XB; Diao YW; Zhang LY; Ai J; Liu BL; Huang TX; Cao TT; Tan BB; Xiang D; Zeng CM; Gong J; Zhang Q; Dong SS; Chen J; Liu H; Wu JL; Qi RZ; Xie D; Wang LD; Guan XY
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4631-E4640. PubMed ID: 28533408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
    Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
    Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
    Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
    Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
    Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
    Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered A-to-I RNA editing in human embryogenesis.
    Shtrichman R; Germanguz I; Mandel R; Ziskind A; Nahor I; Safran M; Osenberg S; Sherf O; Rechavi G; Itskovitz-Eldor J
    PLoS One; 2012; 7(7):e41576. PubMed ID: 22859999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
    Keegan LP; Hajji K; O'Connell MA
    Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
    Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
    Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.